📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

NICE guidance on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma (2022)

First Author: Adler A

Attributed to: Calibration of multiple treatment comparisons using individual patient data funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(22)00301-0

PubMed Identifier: 35988573

Publication URI: http://europepmc.org/abstract/MED/35988573

Type: Journal Article/Review

Parent Publication: The Lancet Respiratory Medicine

Issue: 10

ISSN: 2213-2600